Multicenter clinicopathological correlation in dementia.
about
Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic CriteriaMagnetic resonance imaging and magnetic resonance spectroscopy in dementiasProteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.Repair of oxidative DNA damage, cell-cycle regulation and neuronal death may influence the clinical manifestation of Alzheimer's disease.Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease.Neuropathologic substrates of ischemic vascular dementia.Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.Improving CSF Biomarkers' Performance for Predicting Progression from Mild Cognitive Impairment to Alzheimer's Disease by Considering Different Confounding Factors: A Meta-Analysis.Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.Mixed dementia: epidemiology, diagnosis, and treatment.Impact of subcortical ischemic lesions on behavior and cognition.Evolution of the diagnostic criteria for degenerative and cognitive disorders.Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia.Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.The natural history of cognitive decline in Alzheimer's disease.Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis.Pathology and pathogenesis of vascular cognitive impairment-a critical updateVascular risk factors, cognitive decline, and dementiaAntihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention.Comparative analysis of cognitive impairments in lewy body dementia and Alzheimer's disease.Electroencephalogram in the dementia workup.Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective.The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy.Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series.Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study.Brain SPET perfusion in early Alzheimer's disease: where to look?Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project.Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome.Error detection and correction patterns in dementia: a breakdown of error monitoring processes and their neuropsychological correlates.Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic.The validity of clinical diagnoses of dementia in a group of consecutively autopsied memory clinic patients.Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA).
P2860
Q26864063-7C76807B-A06D-400D-A5CE-F0AB107ECD36Q30660816-56389C03-6130-4FC8-B809-56898CA998D1Q33666765-D330B6AE-F960-4E36-9EF5-A0E1121DB6A8Q33719041-14BBDD8A-C4FB-49DD-97DB-F49824C02853Q33769079-AEDB930F-98FF-4406-94E3-A7FEA7F7E6B0Q33922669-72110569-B6AD-4B32-BCC4-23A5F769D6A1Q34088144-CC14C061-2D1C-4ACC-BDEB-337FC4F12635Q34262758-8838D69F-A66B-4755-B7B0-46F8CB78E15EQ34349522-6DE5D64B-2A9B-4F81-8F2C-09D678D2AF54Q34709035-9776F561-C25E-495A-B7BD-AA81A6850F09Q34775417-0F8D68D8-3A7B-4B4D-B7D6-82EE0809D41AQ35024979-107C2889-714A-4393-B1A1-4520EE21E667Q35708394-39C0E6DC-38A6-4390-9229-B72D81D186F1Q36318942-8DC4AC27-D84A-418D-803D-3B880DDC5D30Q36496101-C5172F47-2E26-435C-AF91-3A12DEC7B811Q36501426-61AA9F0F-3F81-446A-9574-3A709F9254AAQ36538775-D28AB88E-1CEC-4689-BD56-6FE09F40C4E0Q36754568-FDBE8D04-3814-49D2-A9A2-D9C4E6C34CDDQ36812802-5375355A-E833-418E-B699-DF26AAF3C3CBQ38029515-02430499-0AEF-4D0E-9237-B05313EEBCE5Q38410806-1D6EB3D2-7E0F-4F60-A3A1-059E4C496033Q45297487-DAB174F0-6AD0-4FD6-93B5-DF412BC5F29EQ46416681-3853F67D-1EF0-4D27-A6DA-4515E6F75F8BQ47837642-807AE616-EA74-47CB-A780-435B64CD2994Q48212849-88C2ECA3-D80C-4511-8505-0B1AFBB7B875Q48290805-E8A2D91B-AC5D-4D93-A647-7F099B4DD3C8Q48398251-7CD3585C-BEA6-44CF-AA32-D1F20843178EQ48481772-84EB26CC-9BC8-4E60-98A0-F43A455A8198Q48656039-CD8D7C65-73D1-42C8-A450-3E1C19F9754BQ50900772-222444DE-889C-4E6C-B909-19F81A511500Q51893743-CD1ADD38-3D10-4015-826F-798C91ED5832Q51964228-6DB3AABB-C40C-44E3-AB8A-19D425B88C6EQ51967222-788E3F83-13DF-4D40-9C20-BA896B564881Q53369663-BD4E507D-2BA0-474A-B3EF-7F8BD3D89FAC
P2860
Multicenter clinicopathological correlation in dementia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Multicenter clinicopathological correlation in dementia.
@en
Multicenter clinicopathological correlation in dementia.
@nl
type
label
Multicenter clinicopathological correlation in dementia.
@en
Multicenter clinicopathological correlation in dementia.
@nl
prefLabel
Multicenter clinicopathological correlation in dementia.
@en
Multicenter clinicopathological correlation in dementia.
@nl
P2093
P356
P1476
Multicenter clinicopathological correlation in dementia.
@en
P2093
P304
P356
10.1176/AJP.152.10.1476
P407
P577
1995-10-01T00:00:00Z